Hair analysis for cannabinoids and amphetamines in a psychosis incidence study

It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated durin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European neuropsychopharmacology 2002-02, Vol.12 (1), p.27-30
Hauptverfasser: Selten, Jean-Paul, Bosman, Ingrid J, de Boer, Douwe, Veen, Natalie D, van der Graaf, Yolanda, Maes, Robert A.A, Kahn, René S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 27
container_title European neuropsychopharmacology
container_volume 12
creator Selten, Jean-Paul
Bosman, Ingrid J
de Boer, Douwe
Veen, Natalie D
van der Graaf, Yolanda
Maes, Robert A.A
Kahn, René S
description It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.
doi_str_mv 10.1016/S0924-977X(01)00129-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71407642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X01001298</els_id><sourcerecordid>71407642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo7vrxE5ScRA_VfDbtSWRRV1j0oIK3kE1SNtKma9IK_femu4sePQ3MPO8M8wBwhtE1Rji_eUUlYVkpxMclwlcIYVJmxR6Y4kLQTBQ52QfTX2QCjmL8TBCntDwEE4xFURAqpuB5rlyAyqt6iC7Cqg1QK-_V0vnWmZgmBqpmvbKdapy3EToPFVzHQa_aMeC8dsZ6bWHsejOcgINK1dGe7uoxeH-4f5vNs8XL49PsbpFpmuMuM0utqSCC5oibnJOKoYoro41OPa1ZaTg3wlqDCGLpXa0IN6nBGS4Zoogeg4vt3nVov3obO9m4qG1dK2_bPkqBGRI5IwnkW1CHNsZgK7kOrlFhkBjJUaTciJSjJYmw3IiURcqd7w70y8aav9TOXAJut4BNb347G2TUbhRhXLC6k6Z1_5z4AVoLg34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71407642</pqid></control><display><type>article</type><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</creator><creatorcontrib>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</creatorcontrib><description>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/S0924-977X(01)00129-8</identifier><identifier>PMID: 11788237</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Amphetamine - analysis ; Amphetamines ; Cannabinoids - analysis ; Cannabis ; Confidence Intervals ; Dopamine Agents - analysis ; Epidemiology ; Female ; Gas Chromatography-Mass Spectrometry - methods ; Hair - chemistry ; Hair analysis ; Humans ; Incidence ; Logistic Models ; Male ; Odds Ratio ; Psychotic Disorders - diagnosis ; Psychotic Disorders - epidemiology ; Psychotic Disorders - psychology ; Schizophrenia ; Substance abuse ; Substance Abuse Detection - methods</subject><ispartof>European neuropsychopharmacology, 2002-02, Vol.12 (1), p.27-30</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</citedby><cites>FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0924-977X(01)00129-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11788237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Selten, Jean-Paul</creatorcontrib><creatorcontrib>Bosman, Ingrid J</creatorcontrib><creatorcontrib>de Boer, Douwe</creatorcontrib><creatorcontrib>Veen, Natalie D</creatorcontrib><creatorcontrib>van der Graaf, Yolanda</creatorcontrib><creatorcontrib>Maes, Robert A.A</creatorcontrib><creatorcontrib>Kahn, René S</creatorcontrib><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</description><subject>Adult</subject><subject>Amphetamine - analysis</subject><subject>Amphetamines</subject><subject>Cannabinoids - analysis</subject><subject>Cannabis</subject><subject>Confidence Intervals</subject><subject>Dopamine Agents - analysis</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Gas Chromatography-Mass Spectrometry - methods</subject><subject>Hair - chemistry</subject><subject>Hair analysis</subject><subject>Humans</subject><subject>Incidence</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Odds Ratio</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - psychology</subject><subject>Schizophrenia</subject><subject>Substance abuse</subject><subject>Substance Abuse Detection - methods</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMo7vrxE5ScRA_VfDbtSWRRV1j0oIK3kE1SNtKma9IK_femu4sePQ3MPO8M8wBwhtE1Rji_eUUlYVkpxMclwlcIYVJmxR6Y4kLQTBQ52QfTX2QCjmL8TBCntDwEE4xFURAqpuB5rlyAyqt6iC7Cqg1QK-_V0vnWmZgmBqpmvbKdapy3EToPFVzHQa_aMeC8dsZ6bWHsejOcgINK1dGe7uoxeH-4f5vNs8XL49PsbpFpmuMuM0utqSCC5oibnJOKoYoro41OPa1ZaTg3wlqDCGLpXa0IN6nBGS4Zoogeg4vt3nVov3obO9m4qG1dK2_bPkqBGRI5IwnkW1CHNsZgK7kOrlFhkBjJUaTciJSjJYmw3IiURcqd7w70y8aav9TOXAJut4BNb347G2TUbhRhXLC6k6Z1_5z4AVoLg34</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Selten, Jean-Paul</creator><creator>Bosman, Ingrid J</creator><creator>de Boer, Douwe</creator><creator>Veen, Natalie D</creator><creator>van der Graaf, Yolanda</creator><creator>Maes, Robert A.A</creator><creator>Kahn, René S</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020201</creationdate><title>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</title><author>Selten, Jean-Paul ; Bosman, Ingrid J ; de Boer, Douwe ; Veen, Natalie D ; van der Graaf, Yolanda ; Maes, Robert A.A ; Kahn, René S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-dbcc37273605d652f40f5adcdc273cc49d55d7eed0204101ca25dd7e541940303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Amphetamine - analysis</topic><topic>Amphetamines</topic><topic>Cannabinoids - analysis</topic><topic>Cannabis</topic><topic>Confidence Intervals</topic><topic>Dopamine Agents - analysis</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Gas Chromatography-Mass Spectrometry - methods</topic><topic>Hair - chemistry</topic><topic>Hair analysis</topic><topic>Humans</topic><topic>Incidence</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Odds Ratio</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - psychology</topic><topic>Schizophrenia</topic><topic>Substance abuse</topic><topic>Substance Abuse Detection - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Selten, Jean-Paul</creatorcontrib><creatorcontrib>Bosman, Ingrid J</creatorcontrib><creatorcontrib>de Boer, Douwe</creatorcontrib><creatorcontrib>Veen, Natalie D</creatorcontrib><creatorcontrib>van der Graaf, Yolanda</creatorcontrib><creatorcontrib>Maes, Robert A.A</creatorcontrib><creatorcontrib>Kahn, René S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Selten, Jean-Paul</au><au>Bosman, Ingrid J</au><au>de Boer, Douwe</au><au>Veen, Natalie D</au><au>van der Graaf, Yolanda</au><au>Maes, Robert A.A</au><au>Kahn, René S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hair analysis for cannabinoids and amphetamines in a psychosis incidence study</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>12</volume><issue>1</issue><spage>27</spage><epage>30</epage><pages>27-30</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>It remains often uncertain whether the use of illicit substances has contributed to the aetiology of psychosis. Gas chromatography–mass spectrometry can be used to detect them in hair of the head. Given a monthly growth rate between 1.0 and 1.5 cm, one can examine hair segments that originated during the pre-psychotic period. We examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. One hundred patients participated in a psychosis incidence study and 64 yielded hair. Refusal was associated with non-Dutch ethnicity, not with a clinical diagnosis of use. A monthly growth rate of 1.5 cm was assumed and 33 specimens were found to be long enough. Cannabinoids or amphetamines were detected in nine specimens. In seven they were not detected, whereas the patients had reported their use. It is likely that their hair grew at a slower rate and that the examined segments belonged to an earlier period of time, during which the substances were not used. Lack of knowledge about the individual hair growth rate is an important limitation to the usefulness of this method.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>11788237</pmid><doi>10.1016/S0924-977X(01)00129-8</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-977X
ispartof European neuropsychopharmacology, 2002-02, Vol.12 (1), p.27-30
issn 0924-977X
1873-7862
language eng
recordid cdi_proquest_miscellaneous_71407642
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Amphetamine - analysis
Amphetamines
Cannabinoids - analysis
Cannabis
Confidence Intervals
Dopamine Agents - analysis
Epidemiology
Female
Gas Chromatography-Mass Spectrometry - methods
Hair - chemistry
Hair analysis
Humans
Incidence
Logistic Models
Male
Odds Ratio
Psychotic Disorders - diagnosis
Psychotic Disorders - epidemiology
Psychotic Disorders - psychology
Schizophrenia
Substance abuse
Substance Abuse Detection - methods
title Hair analysis for cannabinoids and amphetamines in a psychosis incidence study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A47%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hair%20analysis%20for%20cannabinoids%20and%20amphetamines%20in%20a%20psychosis%20incidence%20study&rft.jtitle=European%20neuropsychopharmacology&rft.au=Selten,%20Jean-Paul&rft.date=2002-02-01&rft.volume=12&rft.issue=1&rft.spage=27&rft.epage=30&rft.pages=27-30&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/S0924-977X(01)00129-8&rft_dat=%3Cproquest_cross%3E71407642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71407642&rft_id=info:pmid/11788237&rft_els_id=S0924977X01001298&rfr_iscdi=true